Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2025-12-24 @ 12:19 PM
Study NCT ID:
NCT03881761
Status:
UNKNOWN
Last Update Posted:
2019-03-21
First Post:
2019-03-16
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma
Sponsor:
Henan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-16
First Submit QC Date:
None
Study First Post Date:
2019-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-19
Last Update Post Date:
2019-03-21
Last Update Post Date Type:
ACTUAL